Searched for
BIOCON API BUSINESS
Biocon Q4 Results: Net profit down 57% at Rs 198.6 croreBiocon Ltd reported a 56.8% drop in Q4 net profit to Rs 198.6 crore, impacted by an Rs 80.4 crore exceptional item. Despite this, consolida...08 May, 2026, 10.05 AM IST- Biocon reports 95% YoY decline in net profit, operating revenue up 15%Biocon's Q1 net profit declined 95% year-on-year, but on a like-for-like basis, profit after tax increased by 65%. Revenue grew 15% to Rs 3...08 Aug, 2025, 06.19 AM IST
- Biocon drops plan to launch weight-loss drugs in China, executive saysBiocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense local competition...27 Jun, 2025, 10.36 AM IST
- Biocon Q4 Results: Net profit drops 57% to Rs 136 croreTotal revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% ...16 May, 2024, 10.05 PM IST
- Biocon Q3 Results: PAT at Rs 660 crore vs Rs 42-crore loss a year agoThe company said the revenue growth was supported by income from the divesture of two non-core business assets of Biocon Biologics' branded...08 Feb, 2024, 10.52 PM IST
- Biocon denies plans to sell $1.5 billion generic API businessBiocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valu...15 Dec, 2023, 01.16 PM IST
- Biocon weighs sale of $1.5 billion generic API businessThe Kiran Mazumdar-Shaw helmed company made a huge bet on biosimilars by acquiring a portfolio of drugs from global drug major Viatris for ...15 Dec, 2023, 10.05 AM IST
- Biocon Q2 Results: Profit zooms 168% YoY to Rs 126 crore; revenue jumps 49%EBITDA for the quarter increased by 68% YoY to Rs 900 crore, representing an EBITDA margin of 25% versus 22% in the same period last year. ...10 Nov, 2023, 06.41 PM IST
- Biocon Q1 Results: Profit drops 30% YoY to Rs 101 crore, revenue jumps 59%The company attributed the drop in net profit to depreciation, amortisation and interest increase of Rs 353 crore over last year primarily ...10 Aug, 2023, 10.52 PM IST
- Viatris puts India API business on the blockHowever, the API sale process, which was launched a couple of months ago, has seen no serious buyers, added multiple people aware of the de...30 Mar, 2023, 12.36 AM IST
- Kotak fund invests Rs 1070 crore in BioconEshwar Karra, CEO – Kotak Special Situations Fund at Kotak Investment Advisors said, We are delighted to partner with Biocon and this acqui...22 Feb, 2023, 10.16 PM IST
- Biocon's growth drivers are in place: 5 reasons it is this week's stock pickImproving prospects of the pharma industry, growth in the global generics market, expanded product portfolio and cost reduction initiatives...03 Oct, 2022, 06.30 AM IST
- Biocon plunges 5% even as Q1 profit rises 71%Siddharth Mittal, CEO & Managing Director, Biocon, said, “The strong year-on-year growth of the segment was driven by both our API and Form...28 Jul, 2022, 01.57 PM IST
- Hold Biocon, target price Rs 380: ICICI DirectBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 44314.15 crore) operating in Pharmaceuticals secto...02 May, 2022, 11.18 AM IST
- Biocon acquires Vishakapatnam-based company's manufacturing plantBiotechnology major Biocon today said it has acquired a manufacturing unit of Vishakapatnam- based Acacia Lifesciences for an undisclosed a...01 Oct, 2015, 08.27 PM IST
- Biocon to invest 10% of biopharma revenues on R&D next fiscalThe Bengaluru-based company has spent Rs 47 crore on R&D in the third quarter of this fiscal, an increase of 124 per cent over the correspo...01 Feb, 2015, 11.53 AM IST
- Biocon completes divestment of its enzyme businessBiotechnology firm, Biocon on Monday said it has completed all activities related to the divestment of enzymes business to Novozymes South ...01 Oct, 2007, 01.39 PM IST
Load More
